Emphysème
Revu par Dr Surangi Mendis, MRCGPDernière mise à jour par Dr Philippa Vincent, MRCGPDernière mise à jour 2 juin 2023
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
- Ajouter aux sources préférées sur Google
Dans cette série :Maladie pulmonaire obstructive chroniqueSpirométrieInhalateurs pour MPOCMucolytiquesBronchodilatateurs orauxExacerbations aiguës de la BPCO
L'emphysème est une affection pulmonaire progressive qui est une forme de maladie pulmonaire obstructive chronique. Le tabagisme est la cause la plus courante de l'emphysème.
En un coup d'œil
L'emphysème est une affection pulmonaire qui provoque un essoufflement et une toux persistante.
Il endommage les alvéoles dans les poumons, réduisant la quantité d'oxygène transférée au sang.
Smoking is the leading cause of emphysema, but passive smoking and pollution are also risk factors.
Les symptômes s'aggravent avec le temps, rendant finalement les activités normales difficiles.
Arrêter de fumer est le traitement le plus important et peut ralentir la progression de la maladie.
Le traitement comprend des inhalateurs et des comprimés, et parfois une chirurgie pour les cas avancés.
Les complications peuvent inclure des infections pulmonaires fréquentes, des poumons effondrés et des problèmes cardiaques.
What is emphysema?
Emphysema is a lung condition that causes shortness of breath and cough. Over time, the inner walls of the air sacs in the lungs (alveoli) are weakened and the lining of the alveoli becomes damaged. This causes a smaller number of larger air spaces instead of lots of normal small ones.
The smaller number of larger air sacs causes a reduction in the overall surface area of the lungs. This means that less oxygen can be transferred from the air being breathed into the lungs into the bloodstream.
Most people with emphysema also have a condition called chronic bronchitis. Chronic bronchitis causes inflammation in the tubes (bronchi) that carry the air to and from the lungs. This leads to a persistent cough and further reduces the air that is breathed into the lungs. Emphysema and chronic bronchitis are the two conditions that make up chronic obstructive pulmonary disease (COPD).
Emphysema symptoms
The main symptoms of emphysema are essoufflement et a cough, which usually begin gradually. As the emphysema in the lungs becomes worse, the symptoms also deteriorate.
Emphysema is a long-term condition that usually progresses over a number of years. Progress is often slow but can be faster in some people. There may be no symptoms for a long time and sometimes emphysema is found on chest x-rays even in people with no or few symptoms.
As the shortness of breath and the cough become progressively worse, it can become difficult to continue with normal activities and mobility. Emphysema eventually causes shortness of breath even at rest.
Stages of emphysema / COPD
Stage 1 - mild
Lung function is reduced to around 80% and symptoms are mild. They can often be assumed to be "just a smoker's cough". The cough increases at this stage and often there is production of phlegm. The most important action in this mild stage is to stop smoking which can reduce the worsening of emphysema. Exercise is important as well to try and increase the functioning of the lungs.
Stage 2 - moderate
Lung function is reduced to between 50 and 79%. This is the commonest stage for emphysema and COPD to be diagnosed as the symptoms are more troublesome. The symptoms are usually the same as in mild emphysema but more persistent with daily cough and phlegm.
Stage 3 - severe
Lung function is reduced to between 30 and 49% of normal. Symptoms are worse and more frequent at this stage. It is common to get more frequent infections as the lungs are no longer able to work to expel bacteria and viruses. It is usually difficult at this stage to exercise without getting out of breath very quickly.
Stage 4 - very severe
Lung function is reduced to less than 30%. This stage is also called "end-stage" emphysema or "end-stage" COPD because it is so severe and can be life-threatening; however, it is common to live for several years at this stage, but with reduced quality of life. Weight loss is common at this stage.
How common is emphysema?
In the UK it is thought that around 1.2 million people have COPD. This number represents 2 out of every 100 of the population, or between 4-5 out of 100 of all people aged over 40. It is much commoner in the North of England and in deprived areas. The rates of emphysema and COPD in the 10% most-deprived areas is double that in the least-deprived areas. The numbers of people with emphysema and COPD has not decreased in recent years, unlike most chronic health conditions.
Risk factors for and causes of emphysema
Factors that increase the risk of developing emphysema include:
Tabagisme. Emphysema is most likely to develop in cigarette smokers; however, cigar and pipe smokers also are susceptible. The risk for all types of smokers increases with the number of years and amount of tobacco smoked. Around 50% of smokers will develop emphysema with around 20% of smokers developing more severe symptoms. 80% of deaths from COPD are related to smoking.
Âge. Although the lung damage that occurs in emphysema develops gradually, most people with tobacco-related emphysema begin to experience symptoms of the disease between the ages of 40 and 60.
Tabagisme passif. This means breathing in the smoke from someone else's cigarette, pipe or cigar. Being around secondhand smoke increases the risk of emphysema.
Exposure to fumes or dust. People breathing fumes from certain chemicals or dust from grain, cotton, wood or mining products, are more likely to develop emphysema. This risk is even greater if they also smoke.
Exposure to indoor and outdoor pollution. Breathing indoor pollutants (such as fumes from heating fuel), as well as outdoor pollutants (such as car exhaust) increases the risks of emphysema.
Déficit en alpha-1-antitrypsine. There is a rare genetic disorder called alpha-1-antitrypsin deficiency which leads to an inherited deficiency of a protein which protects the elastic structures in the lungs. People with this condition have a significantly higher risk of emphysema at a young age if they smoke. This can be diagnosed with a simple blood test.
Diagnosing emphysema
What tests are needed?
The most common test used in helping to diagnose the condition is called spirometry. Other tests include a radiographie thoracique et analyses de sang to help exclude other serious conditions. Occasionally, a special tomodensitométrie (TDM) of the chest - high-resolution CT - is needed.
Emphysema treatment
The most important part of treatment is to reduce exposure to any cause - particularly to avoid smoking, including passive smoking. The treatment for many people with emphysema is the same as for maladie pulmonaire obstructive chronique (MPOC) and includes inhalers and tablets to try and reduce the volume of phlegm produced.
Surgery (such as lung volume reduction surgery or a lung transplant) may be considered for advanced severe emphysema.
In the UK, the National Institute for Health and Care Excellence (NICE) recommends that endobronchial valve insertion to reduce lung volume can be considered as a treatment option. An endobronchial valve is a small one-way valve, which is placed in an airway (bronchus), usually using a bronchoscope. The valve allows air to flow out of the lung when breathing out but blocks air from entering that lung when breathing in. This helps to remove the excess air that is trapped in the lungs in emphysema.
Complications of emphysema
People who have emphysema are also more likely to develop:
Chest infections. These can occur frequently.
Collapsed lung (pneumothorax). A collapsed lung can be life-threatening in people who have severe emphysema, because the function of their lungs is already so compromised. This is uncommon but serious when it occurs.
Problèmes cardiaques. Emphysema can increase the pressure in the arteries that connect the heart and lungs. This can cause failure of the right side of the heart, which pumps blood to the lungs (this condition is called cor pulmonale).
Large holes in the lungs (bullae). The bullae can be as very large. These bullae reduce the transfer of oxygen into the bloodstream and also increase the risk of a pneumothorax.
Preventing emphysema
This risk of emphysema can be greatly reduced by:
Ne pas fumer.
Avoiding passive smoking.
Wearing a mask to protect the lungs if working with chemical fumes or dust.
Sélections des patients pour Maladie pulmonaire obstructive chronique

Poitrine et poumons
Utilisation de l'oxygénothérapie dans la BPCO
Oxygen is used for some chronic lung conditions. Chronic obstructive pulmonary disease (COPD) is one of these conditions. Long-term oxygen use can help to relieve the strain on the heart. However, it does not relieve breathlessness.
par Dr Oliver Starr, MRCGP

Poitrine et poumons
Inhalateurs pour MPOC
An inhaler is a device holding a medicine that you take by breathing in (inhaling). Inhalers are often used to treat chronic obstructive pulmonary disease (COPD). There are many different types of inhaler, which can be confusing. The purpose of this leaflet is to give information on the medicines that are inside inhalers, the various types of inhaler device, and some general information about inhalers.
par Dr Hayley Willacy, FRCGP
Questions fréquemment posées
Qu'est-ce que l'insertion de valve endobronchique et comment cela aide-t-il en cas d'emphysème sévère ?
L'insertion de valve endobronchique est une procédure où une petite valve unidirectionnelle est placée dans une voie respiratoire (bronche) à l'aide d'un bronchoscope. Cette valve permet à l'air de s'échapper du poumon lorsque vous expirez, mais empêche l'air d'entrer dans ce poumon lorsque vous inspirez. Cela aide à éliminer l'excès d'air qui se retrouve piégé dans les poumons en raison de l'emphysème, ce qui peut améliorer la respiration.
Can emphysema lead to other health problems?
Oui, l'emphysème peut augmenter votre risque de développer plusieurs autres problèmes de santé. Ceux-ci incluent des infections thoraciques fréquentes, un poumon effondré (pneumothorax) et des problèmes cardiaques, notamment une augmentation de la pression dans les artères reliant le cœur et les poumons, ce qui peut entraîner une insuffisance du côté droit du cœur (cor pulmonale). De grands trous appelés bulles peuvent également se former dans les poumons, réduisant encore le transfert d'oxygène et augmentant le risque de pneumothorax.
L'emphysème est-il héréditaire ?
Dans un nombre rare de cas, l'emphysème peut être lié à un trouble génétique appelé déficit en alpha-1-antitrypsine. Cette condition signifie que le corps ne produit pas suffisamment d'une protéine qui protège habituellement les structures élastiques des poumons. Si une personne avec ce déficit fume également, elle a un risque significativement plus élevé de développer un emphysème à un âge plus jeune. Cela peut être identifié par un simple test sanguin.
Existe-t-il des moyens de prévenir le développement de l'emphysème ?
Oui, il existe des moyens efficaces pour réduire votre risque de développer un emphysème. Le plus important est de ne pas fumer et d'éviter l'exposition à la fumée passive. Si vous travaillez dans un environnement avec des vapeurs chimiques ou de la poussière, porter un masque de protection pour vos poumons peut également réduire considérablement votre risque.
Lectures complémentaires et références
- Pahal P, Sharma S; Emphysema. StatPearls Publishing. 2018.
- Visca D, Aiello M, Chetta A; Cardiovascular function in pulmonary emphysema. Biomed Res Int. 2013;2013:184678. doi: 10.1155/2013/184678. Epub 2013 Dec 3.
- Endobronchial valve insertion to reduce lung volume in emphysema; NICE Interventional procedure guidance, December 2017
- British Lung Foundation; Chronic obstructive pulmonary disease (COPD) statistics, 2019.
À propos de l'auteurVoir la biographie complète

Dr Philippa Vincent, MRCGP
Médecin généraliste, Auteur médical
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dr Philippa Vincent est un médecin généraliste du NHS travaillant dans le nord de Londres.
À propos du critiqueVoir la biographie complète

Dr Surangi Mendis, MRCGP
Consultant and Medical Author
MBBS, BSc (1st), MRCGP (2014), DFSRH, PGcert otology and audiology
Surangi Mendis is a consultant in Audiovestibular Medicine and Neuro-otology at The Royal National ENT and Eastman Dental Hospitals, UCLH.
Historique de l'article
Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
Article également disponible en Anglais, Allemand, Espagnol, Français, Italien, Portugais, Hindi, Hébreu, Arabe, and Suédois.
Prochaine révision prévue : 12 mai 2028
2 juin 2023 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

Vous ne vous sentez pas bien ?
Évaluez vos symptômes en ligne gratuitement
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.